As of 2026-10-17, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (14.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -746.6%.
The range of the Relative Valuation is (9.63) - (18.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 19.6x | 13.0x |
| Forward P/E multiples | 8.8x - 16.9x | 13.4x |
| Fair Price | (9.63) - (18.54) | (14.42) |
| Upside | -531.9% - -931.4% | -746.6% |
| Date | P/E |